These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 6601241)
1. The challenge of hereditary angioneurotic edema. Donaldson VH N Engl J Med; 1983 May; 308(18):1094-5. PubMed ID: 6601241 [No Abstract] [Full Text] [Related]
2. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240 [TBL] [Abstract][Full Text] [Related]
3. Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Donaldson VH; Rosen FS; Bing DH Trans Assoc Am Physicians; 1977; 90():174-83. PubMed ID: 148134 [No Abstract] [Full Text] [Related]
4. Structural and functional characterization of factor XII. Tans G; Rosing J Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074 [TBL] [Abstract][Full Text] [Related]
5. Interactions of C1(-)-inhibitors from normal persons and patients with type II hereditary angioneurotic edema with purified activated Hageman factor (factor XIIa). Donaldson VH; Mitchell BH; Everson B; Ratnoff OD Blood; 1990 Feb; 75(4):911-21. PubMed ID: 2302459 [TBL] [Abstract][Full Text] [Related]
6. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent. Kaplan AP; Joseph K Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087 [TBL] [Abstract][Full Text] [Related]
7. Distinction between hereditary and acquired angioneurotic oedema according to the complement system. Brecy H; Hartmann L Biomedicine; 1975 Oct; 23(8):328-34. PubMed ID: 1231927 [TBL] [Abstract][Full Text] [Related]
9. The second component of complement (C2) as an index of hereditary angioneurotic edema. Sobel AT; Moisy M; Belghiti D; Gabay Y; Lagrue G J Clin Lab Immunol; 1978 Nov; 1(3):179-81. PubMed ID: 756467 [TBL] [Abstract][Full Text] [Related]
10. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Initiation of blood coagulation]. Saito H Rinsho Byori; 1985 Sep; 33(9):960-5. PubMed ID: 3878416 [No Abstract] [Full Text] [Related]
11. Hereditary and acquired deficiencies of C1 inhibitor. Davis AE Immunodefic Rev; 1989; 1(3):207-26. PubMed ID: 2698641 [TBL] [Abstract][Full Text] [Related]
12. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor. Czendlik C; Lämmle B; Duckert F Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997 [TBL] [Abstract][Full Text] [Related]
13. Studies on serum factors mediating complement consumption by house dust allergens. Berrens L; Guikers CL; van Dijk AG Monogr Allergy; 1979; 14():150-4. PubMed ID: 503070 [No Abstract] [Full Text] [Related]
14. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. Gallimore MJ; Friberger P Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564 [No Abstract] [Full Text] [Related]
15. Major inhibitors of the contact phase coagulation factors. Schapira M Semin Thromb Hemost; 1987 Jan; 13(1):69-78. PubMed ID: 2436302 [No Abstract] [Full Text] [Related]
16. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack]. Mikami A; Kohno M Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041 [TBL] [Abstract][Full Text] [Related]